Ankle Injuries, Imaging and Prevention Program Effectiveness in New Army Recruits
Launched by UNIVERSITY OF HAIFA · Jun 16, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well a special exercise program can help prevent ankle sprains in new Army recruits. The study involves a thorough check-up to assess the recruits’ muscles, joints, and balance, followed by a targeted exercise intervention designed to strengthen their ankles and improve their agility. After completing the program, the recruits will be evaluated again to see how effective the exercises were in preventing injuries.
To participate in this trial, recruits need to be male soldiers aged 18 to 22. Unfortunately, those with known bone diseases or those who have had orthopedic surgery won't be eligible. The trial is currently recruiting participants, so if you meet the age requirement and are interested in helping improve ankle injury prevention in the military, this could be a great opportunity.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • soldiers ages 18-22
- Exclusion Criteria:
- • knows disease of the bones
- • before orthopedic surgery
About University Of Haifa
The University of Haifa, a leading institution in Israel renowned for its interdisciplinary research and academic excellence, actively engages in clinical trials to advance scientific knowledge and improve healthcare outcomes. With a strong focus on innovation, the university collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous research that addresses pressing medical challenges. Its commitment to ethical standards and adherence to regulatory requirements underpin the integrity of its clinical trials, fostering an environment that promotes the translation of research findings into practical applications for patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Netanya, , Israel
Patients applied
Trial Officials
Gali Dar, Prof.
Principal Investigator
University of Haifa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported